PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer

PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer

<b>Keywords: </b>chemorefractory metastatic colorectal cancer; regorafenib; circulating tumour cells; PD-L1; PLR; liquid biopsy; acquired resistance; targeted therapy

Bibliographic Details
Main Authors: Lucrezia Raimondi, Filippo Maria Raimondi, Laura Di Benedetto, Giuseppe Cimino, Gian Paolo Spinelli
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:International Journal of Molecular Sciences
Subjects:
n/a
Online Access:https://www.mdpi.com/1422-0067/21/18/6907

Internet

https://www.mdpi.com/1422-0067/21/18/6907

Similar Items